BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18650173)

  • 1. Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
    Veeraputhiran M; Sundermeyer M
    Clin Lung Cancer; 2008 Jul; 9(4):232-4. PubMed ID: 18650173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhabdomyolysis secondary to the interaction of statins with macrolides in a renal transplant patient].
    Valero R; Rodrigo E; Zubimendi JA; Arias M
    Nefrologia; 2004; 24(4):382-3. PubMed ID: 15455502
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
    Lasocki A; Vote B; Fassett R; Zamir E
    Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.
    Schmidt GA; Hoehns JD; Purcell JL; Friedman RL; Elhawi Y
    J Am Board Fam Med; 2007; 20(4):411-6. PubMed ID: 17615423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
    Johnson JR; Cohen M; Sridhara R; Chen YF; Williams GM; Duan J; Gobburu J; Booth B; Benson K; Leighton J; Hsieh LS; Chidambaram N; Zimmerman P; Pazdur R
    Clin Cancer Res; 2005 Sep; 11(18):6414-21. PubMed ID: 16166415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant drug interaction: phenytoin toxicity due to erlotinib.
    Grenader T; Gipps M; Shavit L; Gabizon A
    Lung Cancer; 2007 Sep; 57(3):404-6. PubMed ID: 17383767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulminant hepatic failure secondary to erlotinib.
    Liu W; Makrauer FL; Qamar AA; Jänne PA; Odze RD
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):917-20. PubMed ID: 17625975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erlotinib-induced acute interstitial lung disease associated with extreme elevation of the plasma concentration in an elderly non-small-cell lung cancer patient.
    Tsubata Y; Hamada A; Sutani A; Isobe T
    J Cancer Res Ther; 2012; 8(1):154-6. PubMed ID: 22531540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer.
    Smith J
    Clin Ther; 2005 Oct; 27(10):1513-34. PubMed ID: 16330289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-associated rhabdomyolysis triggered by drug-drug interaction with itraconazole.
    Dybro AM; Damkier P; Rasmussen TB; Hellfritzsch M
    BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27605198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer.
    Hotta K; Kiura K
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):991-7. PubMed ID: 21806322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyolysis induced by simvastatin and ketoconazole treatment.
    Gilad R; Lampl Y
    Clin Neuropharmacol; 1999; 22(5):295-7. PubMed ID: 10516882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlotinib and maintenance therapy of non-small cell lung cancer. Inadequate assessment; authorisation unjustified.
    Prescrire Int; 2011 Oct; 20(120):234. PubMed ID: 21970082
    [No Abstract]   [Full Text] [Related]  

  • 14. Erlotinib-induced scalp perifolliculitis.
    Rallis E; Petronic-Rosic V; Korfitis C
    Skinmed; 2012; 10(2):70-1. PubMed ID: 22545319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful re-challenge of daptomycin therapy after initial rhabdomyolysis with co-administration of simvastatin.
    Bland CM; Bookstaver PB; Thomas S
    Int J Antimicrob Agents; 2011 Dec; 38(6):549-50. PubMed ID: 21958456
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myopathy and rhabdomyolysis after treatment with simvastatin, amlodipine, and roxithromycin].
    Skovbølling SL; Lindelof M
    Ugeskr Laeger; 2014 Oct; 176(41):. PubMed ID: 25331664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of erlotinib in patients with advanced non-small cell lung cancer: a pooled analysis of randomized trials.
    Gao H; Ding X; Wei D; Cheng P; Su X; Liu H; Aziz F; Wang D; Zhang T
    Anticancer Drugs; 2011 Oct; 22(9):842-52. PubMed ID: 21808188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil-simvastatin interaction: possible cause of rhabdomyolysis?
    Gutierrez CA
    Am Fam Physician; 2001 Feb; 63(4):636-7. PubMed ID: 11237079
    [No Abstract]   [Full Text] [Related]  

  • 19. Erlotinib-induced pustular eruption.
    Cusano F; Ferrara G; Barletta E; Ingordo V
    G Ital Dermatol Venereol; 2009 Feb; 144(1):93-6. PubMed ID: 19218915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyolysis in association with simvastatin and amiodarone.
    Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
    Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.